1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Public Health
  4. Volume 43, 2022
  5. Article

Annual Review of Public Health

Volume 43, 2022

Public Health Roles in Addressing Commercial Determinants of Health

Abstract

The shared challenges posed by the production and distribution of health-harming products have led to growing recognition of the need for policy learning and transfer across problems, populations, and social contexts. The commercial determinants of health (CDoH) can serve as a unifying concept to describe the population health consequences arising from for-profit actors and activities, along with the social structures that sustain them. Strategies to mitigate harms from CDoH have focused on behavioral change, regulation, fiscal policies, consumer and citizen activism, and litigation. While there is evidence of effective measures for each strategy, approaches that combine strategies are generally more impactful. Filling gaps in evidence can inform ways of adapting these strategies to specific populations and social contexts. Overall, CDoH are addressed most effectively not through siloed efforts to reduce consumption of health-harming products, but instead as a set of integrated strategies to reduce exposures to health-harming commercial actors and activities.

Keyword(s): commercial determinants of health, corporations, public health interventions

[Erratum, Closure]

An erratum has been published for this article:
Erratum: Public Health Roles in Addressing Commercial Determinants of Health
Loading

Article metrics loading...

/content/journals/10.1146/annurev-publhealth-052220-020447
2022-04-05
2024-09-18
Loading full text...

Full text loading...

/deliver/fulltext/publhealth/43/1/annurev-publhealth-052220-020447.html?itemId=/content/journals/10.1146/annurev-publhealth-052220-020447&mimeType=html&fmt=ahah

Literature Cited

  1. 1. 
    Achenbach J, Rowland C, Zezima K, Davis AC. 2020.. Johnson & Johnson, three other companies close in on $26 billion deal on opioid litigation. . Washington Post, Nov. 5. https://www.washingtonpost.com/health/opioid-settlement-drug-distributors/2020/11/05/6a8da214-1fc7-11eb-b532-05c751cd5dc2_story.html
    [Google Scholar]
  2. 2. 
    Adams J, Mytton O, White M, Monsivais P. 2016.. Why are some population interventions for diet and obesity more equitable and effective than others? The role of individual agency. . PLOS Med. 13:(4):e1001990
     [Crossref] [Google Scholar]
  3. 3. 
    Aguilar A, Gutierrez E, Seira E. 2021.. The effectiveness of sin food taxes: evidence from Mexico. . J. Health Econ. 77::102455
     [Crossref] [Google Scholar]
  4. 4. 
    Akinaka C, Biderman D, Hussey J, Klein M, LaMonica R, et al. 2020.. Food litigation year in review 2019—a look at key issues facing our industry. Rep. , Perkins Coie, Seattle, WA:. https://www.jdsupra.com/legalnews/food-litigation-year-in-review-2019-a-99200/
    [Google Scholar]
  5. 5. 
    Alderman J, Daynard DA. 2006.. Applying lessons from tobacco litigation to obesity lawsuits. . Am. J. Prev. Med. 30:(1):82–88
     [Crossref] [Google Scholar]
  6. 6. 
    Anaf J, Baum F, Fisher M, Friel S. 2020.. Civil society action against transnational corporations: implications for health promotion. . Health Promot. Int. 35:(4):877–87
     [Crossref] [Google Scholar]
  7. 7. 
    Anderson M, Toor S, Rainie L, Smith A. 2018.. Activism in the social media age. Rep., Pew Res. Cent., Washington, DC:. https://www.pewresearch.org/internet/2018/07/11/activism-in-the-social-media-age/
    [Google Scholar]
  8. 8. 
    Backholer K, Sarink D, Beauchamp A, Keating C, Loh V, et al. 2016.. The impact of a tax on sugar-sweetened beverages according to socio-economic position: a systematic review of the evidence. . Public Health Nutr. 19:(17):3070–84
     [Crossref] [Google Scholar]
  9. 9. 
    Bader P, Boisclair D, Ferrence R. 2011.. Effects of tobacco taxation and pricing on smoking behavior in high risk populations: a knowledge synthesis. . Int. J. Environ. Res. Public Health 8:(11):4118–39
     [Crossref] [Google Scholar]
  10. 10. 
    Barennes H, Slesak G, Goyet S, Aaron P, Srour LM. 2016.. Enforcing the International Code of Marketing of Breast-milk Substitutes for better promotion of exclusive breastfeeding: Can lessons be learned?. J. Hum. Lact. 32:(1):20–27
     [Crossref] [Google Scholar]
  11. 11. 
    Barlow P, Birkbeck CD, Fukuda-Parr S, Grover A, McNeill D, et al. 2017.. Trade and investment agreements: implications for health protection. . J. World Trade 51:(1):159–82
     [Google Scholar]
  12. 12. 
    Bero L. 2003.. Implications of the tobacco industry documents for public health and policy. . Annu. Rev. Public Health 24::267–88
     [Crossref] [Google Scholar]
  13. 13. 
    Braithwaite J, Drahos P. 2000.. Global Business Regulation. Cambridge, UK:: Cambridge Univ. Press
     [Google Scholar]
  14. 14. 
    Brandt AM. 2007.. The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product That Defined America. New York:: Basic
     [Google Scholar]
  15. 15. 
    Cadan Y, Mokgopo A, Vondrich C. 2020.. Fossil free. $11 trillion and counting. Rep., 350.org, Boston:. https://631nj1ki9k11gbkhx39b3qpz-wpengine.netdna-ssl.com/divestment/wp-content/uploads/sites/52/2019/09/FF_11Trillion-WEB.pdf
    [Google Scholar]
  16. 16. 
    Campaign for Tobacco-Free Kids. 2021.. Major litigation victories from around the world. . Tobacco Control Laws. https://www.tobaccocontrollaws.org/litigation/major_litigation_decisions
    [Google Scholar]
  17. 17. 
    Cashin C, Sparkes S, Bloom D. 2017.. Earmarking for health. From theory to practice. Work. Pap. 5 , World Health Organ., Geneva:. https://apps.who.int/iris/handle/10665/255004
    [Google Scholar]
  18. 18. 
    Chaloupka FJ, Powell LM, Warner KE. 2019.. The use of excise taxes to reduce tobacco, alcohol, and sugary beverage consumption. . Annu. Rev. Public Health 40::187–201
     [Crossref] [Google Scholar]
  19. 19. 
    Chan M. 2013.. WHO Director-General addresses health promotion conference. Opening address at the 8th Global Conference on Health Promotion, Helsinki:. https://www.who.int/director-general/speeches/detail/who-director-general-addresses-health-promotion-conference
    [Google Scholar]
  20. 20. 
    Chau JY, Kite J, Ronto R, Bhatti A, Bonfligioli C. 2019.. Talking about a nanny nation: investigating the rhetoric framing public health debates in Australian news media. . Public Health Res. Pract. 29:(3):e2931922
     [Crossref] [Google Scholar]
  21. 21. 
    Chung-Hall J, Craig L, Gravely S, Sansone N, Fong GT. 2019.. Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group. . Tob. Control 28:(Suppl. 2):s119–28
     [Crossref] [Google Scholar]
  22. 22. 
    Coggon J. 2018.. The nanny state debate: a place where words don't do justice. Rep., Fac. Public Health, Univ. Bristol Law School, London:. https://www.fph.org.uk/media/1972/fph-nannystatedebate-report-final.pdf
    [Google Scholar]
  23. 23. 
    Colchero M, Rivera-Dommarco J, Popkin B, Ng SW. 2017.. In Mexico, evidence of sustained consumer response two years after implementing a sugar-sweetened beverage tax. . Health Aff. 36:(3):564–71
     [Crossref] [Google Scholar]
  24. 24. 
    Collin J. 2012.. Tobacco control, global health policy and development: towards policy coherence in global governance. . Tob. Control 21:(2):274–80
     [Crossref] [Google Scholar]
  25. 25. 
    Collin J, Casswell S. 2016.. Alcohol and the Sustainable Development Goals. . Lancet 387::2582–83
     [Crossref] [Google Scholar]
  26. 26. 
    Cutler DM. 2004.. Behavioral health interventions: What works and why?. In Critical Perspectives on Racial and Ethnic Differences in Health in Late Life, ed. NB Anderson, RA Bulatao, B Cohen , pp. 643–76. Washington, DC:: Natl. Acad. Press
     [Google Scholar]
  27. 27. 
    Daynard RA, Hash LE, Robbins A. 2002.. Food litigation: lessons from the tobacco wars. . JAMA 288:(17):2179
     [Crossref] [Google Scholar]
  28. 28. 
    De Lacy-Vawdon C, Livingstone C. 2020.. Defining the commercial determinants of health: a systematic review. . BMC Public Health 20::1022
     [Crossref] [Google Scholar]
  29. 29. 
    Doetinchem O. 2010.. Hypothecation of tax revenue for health. World Health Rep. Backgr. Pap. 51 , World Health Organ., Geneva:. https://www.who.int/healthsystems/topics/financing/healthreport/51Hypothecation.pdf
    [Google Scholar]
  30. 30. 
    Endres K, Panagopoulos C. 2017.. Boycotts, buycotts, and political consumerism in America. . Res. Politics 4:(4):2053168017738632
     [Crossref] [Google Scholar]
  31. 31. 
    Esser MB, Jernigan DH. 2018.. Policy approaches for regulating alcohol marketing in a global context: a public health perspective. . Annu. Rev. Public Health 39::385–401
     [Crossref] [Google Scholar]
  32. 32. 
    Fabbri A, Lai A, Grundy Q, Bero LA. 2018.. The influence of industry sponsorship on the research agenda: a scoping review. . Am. J. Public Health 108:(11):e9–16
     [Crossref] [Google Scholar]
  33. 33. 
    Fairchild AL, Rosner D, Colgrove J, Bayer R, Fried LP. 2010.. The EXODUS of public health: what history can tell us about the future. . Am. J. Public Health 100:(1):54–63
     [Crossref] [Google Scholar]
  34. 34. 
    Fed. Elect. Comm. 2021.. Who can and can't contribute. . Federal Election Commission. https://www.fec.gov/help-candidates-and-committees/candidate-taking-receipts/who-can-and-cant-contribute/
    [Google Scholar]
  35. 35. 
    Federici C, Detzel P, Petracca F, Dainelli L, Fattore G. 2019.. The impact of food reformulation on nutrient intakes and health, a systematic review of modelling studies. . BMC Nutr. 5::2
     [Crossref] [Google Scholar]
  36. 36. 
    Field RI. 2009.. When can patients sue drug companies?. P T 34:(5):243–44
     [Google Scholar]
  37. 37. 
    Flynn MB. 2021.. Global capitalism as a societal determinant of health: a conceptual framework. . Soc. Sci. Med. 268::113530
     [Crossref] [Google Scholar]
  38. 38. 
    Fooks GJ, Smith J, Lee K, Holden C. 2017.. Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control. . Glob. Health 13::12
     [Crossref] [Google Scholar]
  39. 39. 
    Freudenberg N, Crosbie E. 2022.. Teaching the commercial determinants of health. . In Commercial Determinants of Health, ed. N Maani, M Petticrew, S Galea . Oxford, UK:: Oxford Univ. Press
     [Google Scholar]
  40. 40. 
    Freudenberg N, Lee K, Buse K, Collin J, Crosbie E, et al. 2021.. Defining priorities for research and action on the commercial determinants of health: a conceptual review. . Am. J. Public Health 111:(12):2202–11
     [Crossref] [Google Scholar]
  41. 41. 
    Garton K, Thow AM, Swinburn B. 2020.. International trade and investment agreements as barriers to food environment regulation for public health nutrition: a realist review. . Int. J. Health Policy Manag. https://doi.org/10.34172/IJHPM.2020.189
    [Crossref] [Google Scholar]
  42. 42. 
    Gortmaker SL, Wang YC, Long MW, Giles CM, Ward ZJ, et al. 2015.. Three interventions that reduce childhood obesity are projected to save more than they cost to implement. . Health Aff. 34:(11):1932–39
     [Crossref] [Google Scholar]
  43. 43. 
    Gostin LO, Wiley LF. 2016.. Public Health Law: Power, Duty, Restraint. Oakland:: Univ. Calif. Press
     [Google Scholar]
  44. 44. 
    Grande D. 2010.. Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention?. J. Gen. Intern. Med. 25:(1):79–83
     [Crossref] [Google Scholar]
  45. 45. 
    Grech A, Allman-Farinelli M. 2015.. A systematic literature review of nutrition interventions in vending machines that encourage consumers to make healthier choices. . Obes. Rev. 16:(12):1030–41
     [Crossref] [Google Scholar]
  46. 46. 
    Green LW, Allegrante JP. 2020.. Practice-based evidence and the need for more diverse methods and sources in epidemiology, public health and health promotion. . Am. J. Health Promot. 34:(8):946–48
     [Crossref] [Google Scholar]
  47. 47. 
    Grier SA, Kumanyika S. 2010.. Targeted marketing and public health. . Annu. Rev. Public Health 31::349–69
     [Crossref] [Google Scholar]
  48. 48. 
    Haffajee R, Mello MM. 2017.. Drug companies’ liability for the opioid epidemic. . N. Engl. J. Med. 377:(24):2301–5
     [Crossref] [Google Scholar]
  49. 49. 
    Han E. 2018.. How one doctor's dream funneled $1.3 trillion away from tobacco companies. . Sydney Morning Herald, Oct. 18. https://www.smh.com.au/business/banking-and-finance/tobacco-free-stamp-jordan-princess-super-20181018-p50adz.html
    [Google Scholar]
  50. 50. 
    Hawkes C. 2007.. Regulating and litigating in the public interest: regulating food marketing to young people worldwide: trends and policy drivers. . Am. J. Public Health 97:(11):1962–73
     [Crossref] [Google Scholar]
  51. 51. 
    Hawkins B, Holden C. 2013.. Framing the alcohol policy debate: industry actors and the regulation of the UK beverage alcohol market. . Crit. Policy Stud. 7:(1):53–71
     [Crossref] [Google Scholar]
  52. 52. 
    Hawkins B, Holden C, Eckhardt J, Lee K. 2018.. Reassessing policy paradigms: a comparison of the global tobacco and alcohol industries. . Glob. Public Health 13:(1):1–19
     [Crossref] [Google Scholar]
  53. 53. 
    Hogg SL, Hill SE, Collin J. 2016.. State-ownership of tobacco industry: a ‘fundamental conflict of interest’ or a ‘tremendous opportunity’ for tobacco control?. Tob. Control 25::367–72
     [Crossref] [Google Scholar]
  54. 54. 
    Holman C, Luneburg W. 2012.. Lobbying and transparency: a comparative analysis of regulatory reform. . Interest Groups Advocacy 1::75–104
     [Crossref] [Google Scholar]
  55. 55. 
    Holman D, Lynch R, Reeves A. 2018.. How do health behavior interventions take account of social context? A literature trend and co-citation analysis. . Health 22:(4):389–410
     [Crossref] [Google Scholar]
  56. 56. 
    Hooker S, Punjabi A, Justesen K, Boyle L, Sherman MD. 2018.. Encouraging health behavior change: eight evidence-based strategies. . Fam. Pract. Manag. 25:(2):31–36
     [Google Scholar]
  57. 57. 
    IARC (Int. Agency Res. Cancer). 2011.. Effectiveness of Tax and Price Policies for Tobacco Control. Lyon, Fr.:: IARC
     [Google Scholar]
  58. 58. 
    Ireland R, Bunn C, Reigh G, Philpott M, Capewell S, Boyland E. 2019.. Commercial determinants of health: advertising of alcohol and unhealthy foods during sporting events. . Bull. World Health Organ. 97::290–95
     [Crossref] [Google Scholar]
  59. 59. 
    Jaichen N, Phulkerd S, Certthkrikul N, Sacks G, Tancharoensathien V. 2018.. Corporate political activity of major food companies in Thailand: an assessment and policy recommendations. . Glob. Health 14::115
     [Crossref] [Google Scholar]
  60. 60. 
    Janardhan S. 2021.. Harnessing trade and investment agreements to promote public health. . Drug Alcohol Rev. 40:(1):41–49
     [Crossref] [Google Scholar]
  61. 61. 
    Javadinasab H, Asl I, Vosoogh-Moghaddam A, Najafi B. 2020.. Comparing selected countries using sin tax policy in sustainable health financing: implications for developing countries. . Int. J. Health Plan. Manag. 35:(1):68–78
     [Crossref] [Google Scholar]
  62. 62. 
    Jepson RG, Harris FM, Platt S, Tannahill C. 2010.. The effectiveness of interventions to change six health behaviours: a review of reviews. . BMC Public Health 10::538
     [Crossref] [Google Scholar]
  63. 63. 
    Johnson DA. 2020.. Confronting corporate power: strategies and phases of the Nestle boycott. . J. Hum. Lact. 36:(4):756–65
     [Crossref] [Google Scholar]
  64. 64. 
    Joyner MJ, Warner DO. 2013.. The syntax of sin taxes: putting it together to improve physical, social, and fiscal health. . Mayo Clin. Proc. 88:(6):536–39
     [Crossref] [Google Scholar]
  65. 65. 
    Kaplan S. 2021.. Juul to pay $40 million to settle N.C. vaping case. . New York Times, June 28. https://www.nytimes.com/2021/06/28/health/juul-vaping-settlement-north-carolina.html
    [Google Scholar]
  66. 66. 
    Kickbusch I. 2012.. Addressing the interface of the political and commercial determinants of health. . Health Promot. Int. 27:(4):427–28
     [Crossref] [Google Scholar]
  67. 67. 
    King BG. 2011.. The tactical disruptiveness of social movements: sources of market and mediated disruption in corporate boycotts. . Soc. Probl. 58:(4):491–517
     [Crossref] [Google Scholar]
  68. 68. 
    Knai C, Petticrew M, Mays N, Capewell S, Cassidy R, et al. 2018.. Systems thinking as a framework for analyzing commercial determinants of health. . Milbank Q. 96:(3):472–98
     [Crossref] [Google Scholar]
  69. 69. 
    Kollewe J, Gayle D. 2021.. Nearly 40% of AstraZeneca investors reject boss's bonus rise. . Guardian, May 11. https://www.theguardian.com/business/2021/may/11/astrazeneca-investors-boss-bonus-covid-vaccine
    [Google Scholar]
  70. 70. 
    Krieger J, Bleich SN, Scarmo S, Ng SW. 2021.. Sugar-sweetened beverage reduction policies: progress and promise. . Annu. Rev. Public Health 42::439–61
     [Crossref] [Google Scholar]
  71. 71. 
    Kunkel DL, Castonguay JS, Filer CR. 2015.. Evaluating industry self-regulation of food marketing to children. . Am. J. Prev. Med. 49:(2):181–87
     [Crossref] [Google Scholar]
  72. 72. 
    Lacy-Nichols J, Marten R. 2021.. Power and the commercial determinants of health: ideas for a research agenda. . BMJ Glob. Health 6:(2):e003850
     [Crossref] [Google Scholar]
  73. 73. 
    Lee K, Freudenberg N, Zenone M, Smith J, Mialon M, et al. 2021.. Measuring the commercial determinants of health and disease: a proposed framework. . Int. J. Health Serv. 52:(1):115–28
     [Crossref] [Google Scholar]
  74. 74. 
    Lehmann U, Rheiner Charles V, Vlassopoulos A, Masset G, Spieldenner J. 2017.. Nutrient profiling for product reformulation: public health and benefits for the consumer. . Proc. Nutr. Soc. 76:(3):255–64
     [Crossref] [Google Scholar]
  75. 75. 
    Lemen RA, Landrigan PJ. 2017.. Toward an asbestos ban in the United States. . Int. J. Env. Res. Public Health 14:(11):1302
     [Crossref] [Google Scholar]
  76. 76. 
    Lencucha R, Thow AM. 2019.. How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention. . Int. J. Health Policy Manag. 8:(9):514–20
     [Crossref] [Google Scholar]
  77. 77. 
    Lima JM, Galea S. 2018.. Corporate practices and health: a framework and mechanisms. . Glob. Health 14::21
     [Crossref] [Google Scholar]
  78. 78. 
    Lynch DJ. 2021.. Biden wants to crack down on corporate tax loopholes, resuming a battle his predecessors lost. . Washington Post, April 20. https://www.washingtonpost.com/us-policy/2021/04/20/corporate-tax-loopholes-biden/
    [Google Scholar]
  79. 79. 
    Maani N, Collin J, Friel S, Gilmore AB, McCambridge J. 2020.. Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks. . Eur. J. Public Health 30:(4):660–64
     [Crossref] [Google Scholar]
  80. 80. 
    Maani N, Van Schalkwyk MC, Petticrew M, Galea S. 2021.. The commercial determinants of three contemporary national crises: how corporate practices intersect with the COVID-19 pandemic, economic downturn, and racial inequity. . Milbank Q. 99:(2):503–18
     [Crossref] [Google Scholar]
  81. 81. 
    Maani N, Van Schalkwyk MC, Petticrew M, Ralston R, Collin J. 2021.. The new WHO Foundation—global health deserves better. . BMJ Glob. Health 6::e004950
     [Crossref] [Google Scholar]
  82. 82. 
    Maloney J. 2019.. As Juul moves abroad, it's leaving some of its U.S. restrictions behind. . Wall Street Journal, Sept. 11. https://www.wsj.com/articles/as-juul-moves-abroad-its-leaving-some-of-its-u-s-restrictions-behind-11568220036
    [Google Scholar]
  83. 83. 
    McKee M, Stuckler D. 2018.. Revisiting the corporate and commercial determinants of health. . Am. J. Public Health 108:(9):1167–70
     [Crossref] [Google Scholar]
  84. 84. 
    Mialon M, Charry DAG, Cediel G, Crosbie E, Scagliusi FB. 2020.. “The architecture of the state was transformed in favour of the interests of companies”: corporate political activity of the food industry in Colombia. . Glob. Health 16:(1):97
     [Crossref] [Google Scholar]
  85. 85. 
    Mialon M, Corvalan C, Cediel G, Scagliusi FB, Reyes M. 2020.. Food industry political practices in Chile: “the economy has always been the main concern. Glob. Health 16::107
     [Crossref] [Google Scholar]
  86. 86. 
    Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, et al. 2020.. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. . BMJ Open 10:(7):e034082
     [Crossref] [Google Scholar]
  87. 87. 
    Michie S, van Stralen MM, West R. 2011.. The behavior change wheel: a new method for characterizing and designing behavior change interventions. . Implement. Sci. 6::42
     [Crossref] [Google Scholar]
  88. 88. 
    Michon K. 2021.. Tobacco litigation: history & recent developments. . NOLO. https://www.nolo.com/legal-encyclopedia/tobacco-litigation-history-and-development-32202.html
    [Google Scholar]
  89. 89. 
    Miracolo A, Sophiea M, Mills M, Kanavos P. 2021.. Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin America. . Health Policy Plan. 36:(5):790–810
     [Crossref] [Google Scholar]
  90. 90. 
    Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, et al. 2013.. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. . Lancet 381:(9867):670–79
     [Crossref] [Google Scholar]
  91. 91. 
    Muggli ME, Crystal HM, Klausner K. 2015.. Transparency as a remedy against racketeering: preventing and restraining fraud by exposing Big Tobacco's dirty secrets. . Tob. Control 24::514–18
     [Crossref] [Google Scholar]
  92. 92. 
    Musolino C, Baum F, Freeman T, Labonté R, Bodini C, Sanders D. 2020.. Global health activists’ lessons on building social movements for Health for All. . Int. J. Equity Health 19:(1):116
     [Crossref] [Google Scholar]
  93. 93. 
    Nagy J. 2019.. Tobacco tax administration: a perspective from the IMF. . In Confronting Illicit Tobacco Trade: A Global Review of Country Experiences, ed. S Dutta , pp. 628–41. Washington, DC:: World Bank Group Glob., Tob. Control Program
     [Google Scholar]
  94. 94. 
    Natl. Acad. Sci. Eng. Med. 2020.. Stronger Food and Drug Regulatory Systems Abroad, ed. GJ Buckley, CE Woteki . Washington, DC:: Natl. Acad. Press. https://doi.org/10.17226/25651
    [Crossref] [Google Scholar]
  95. 95. 
    Ndebele P, Shaikh H, Paichadze N, Bari I, Michaels D. 2020.. Commercial determinants of health: an ethical exploration. . Int. J. Public Health 65::1123–32
     [Crossref] [Google Scholar]
  96. 96. 
    Noel J, Lazzarini Z, Robaina K, Vendrame A. 2017.. Alcohol industry self-regulation: Who is it really protecting?. Addiction 112:(Suppl. 1):57–63
     [Crossref] [Google Scholar]
  97. 97. 
    Nolette P. 2015.. Law enforcement as legal mobilization: reforming the pharmaceutical industry through government litigation. . Law Soc. Inq. 40:(1):123–51
     [Crossref] [Google Scholar]
  98. 98. 
    Ó Cathaoir KE. 2018.. Children's right to freedom from obesity: responsibilities of the food industry. . Nord J. Hum. Rights 36:(2):109–31
     [Crossref] [Google Scholar]
  99. 99. 
    O'Donnell A, Anderson P, Jané-Llopis E, Manthey J, Kaner E. 2019.. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015–18. . BMJ 366::I5274
     [Crossref] [Google Scholar]
  100. 100. 
    OECD. 2021.. Lobbying in the 21st Century: Transparency, Integrity and Access. Paris:: OECD Publ
     [Google Scholar]
  101. 101. 
    Owen DG. 2015.. Products Liability Law. St. Paul, MN:: West Acad, 3rd ed.
     [Google Scholar]
  102. 102. 
    Paichadze N, Werbick M, Ndebele P, Bari I, Hayder AA. 2020.. Commercial determinants of health: a proposed research agenda. . Int. J. Public Health 65::1147–49
     [Crossref] [Google Scholar]
  103. 103. 
    Palmedo PC, Dorfman L, Garza S, Murphy E, Freudenberg N. 2017.. Countermarketing alcohol and unhealthy food: an effective strategy for preventing noncommunicable diseases? Lessons from tobacco. . Annu. Rev. Public Health 38::119–44
     [Crossref] [Google Scholar]
  104. 104. 
    Parra D, de Sá T, Monteiro CA, Freudenberg N. 2018.. Automobile, construction and entertainment business sector influences on sedentary lifestyles. . Health Promot. Int. 33::239–49
     [Google Scholar]
  105. 105. 
    Patel M, Miller M. 2012.. Impact of regulatory science on global public health. . Kaohsiung J. Med. Sci. 28:(7 Suppl.):S5–9
     [Google Scholar]
  106. 106. 
    Retracted article deleted. [ Erratum]
  107. 107. 
    Pimpin L, Sassi F, Corbould E, Friebel R, Webber L. 2018.. Fiscal and pricing policies to improve public health: a review of the evidence. Rep., Public Health Engl., London:. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/743118/Fiscal_and_Pricing_Policies_report_FINAL.pdf
    [Google Scholar]
  108. 108. 
    Public Health Engl. 2015.. Sugar reduction: the evidence for action. Rep., Public Health Engl., London:. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/470179/Sugar_reduction_The_evidence_for_action.pdf
    [Google Scholar]
  109. 109. 
    Public Health Engl. 2015.. Sugar reduction: from evidence into action. Annexe 2: A mixed method review of behavior changes resulting from experimental studies that examine the effect of fiscal measures targeted at high sugar food and non-alcoholic drink. Rep., Public Health Engl., London:. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/470173/Annexe_2._Fiscal_evidence_review.pdf
    [Google Scholar]
  110. 110. 
    Public Health Engl. 2016.. The Public Health Burden of Alcohol and the Effectiveness and Cost-Effectiveness of Alcohol Control Policies. An evidence review. Rep., Public Health Engl., London:. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/733108/alcohol_public_health_burden_evidence_review_update_2018.pdf
    [Google Scholar]
  111. 111. 
    Richards JW, Tye JB, Fischer PM. 1996.. The tobacco industry's code of advertising in the United States: myth and reality. . Tob. Control 5::295–311
     [Crossref] [Google Scholar]
  112. 112. 
    Ross H, Blecher E. 2019.. Illicit trade in tobacco products need not hinder tobacco tax policy reforms and increases. Tobacconomics White Pap., Univ. Ill. Chicago:. https://tobacconomics.org/research/illicit-trade-in-tobacco-products-need-not-hinder-tobacco-tax-policy-reforms-and-increases-white-paper/
    [Google Scholar]
  113. 113. 
    Roughead EE, Gilbert AL, Harvey KJ. 1998.. Self-regulatory codes of conduct: Are they effective in controlling pharmaceutical representatives’ presentations to general medical practitioners?. Int. J. Health Serv. 28:(2):269–79
     [Crossref] [Google Scholar]
  114. 114. 
    RSPH (R. Soc. Public Health). 2017.. Targeting the supply and sale of e-cigarettes to smokers. Brief, RSPH, London:. https://www.rsph.org.uk/static/uploaded/227f64d3-1eab-4d29-bc896d09052ddda4.pdf
    [Google Scholar]
  115. 115. 
    Rudd Cent. Food Policy Obes. 2021.. Sugary drink tax calculator. . UConn Rudd Center for Food Policy and Health. https://uconnruddcenter.org/tax-calculator/
    [Google Scholar]
  116. 116. 
    Ruff K. 2015.. Scientific journals and conflict of interest disclosure: What progress has been made?. Environ. Health 14::45
     [Crossref] [Google Scholar]
  117. 117. 
    Scrinis G, Monteiro CA. 2018.. Ultra-processed foods and the limits of product reformulation. . Public Health Nutr. 21:(1):247–52
     [Crossref] [Google Scholar]
  118. 118. 
    Seiler S, Tuchman A, Yao S. 2021.. The impact of soda taxes: pass-through, tax avoidance, and nutritional effects. . J. Mark. Res. 58:(1):22–49
     [Crossref] [Google Scholar]
  119. 119. 
    Sharma LL, Teret SP, Brownell KD. 2010.. The food industry and self-regulation: standards to promote success and to avoid public health failures. . Am. J. Public Health 100:(2):240–46
     [Crossref] [Google Scholar]
  120. 120. 
    Steele S, Ruskin G, Stuckler D. 2020.. Pushing partnerships: corporate influence on research and policy via the International Life Sciences Institute. . Public Health Nutr. 23:(11):2032–40
     [Crossref] [Google Scholar]
  121. 121. 
    Sugar, Tobacco, and Alcohol Taxes (STAX) Group. 2018.. Sugar, tobacco, and alcohol taxes to achieve the SDGs. . Lancet 391:(10138):2400–1
     [Crossref] [Google Scholar]
  122. 122. 
    Swinburn B, Sacks G, Vandevijvere S, Kumanyika S, Lobstein T, et al. 2013.. INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): overview and key principles. . Obes. Rev. 14:(Suppl. 1):1–12
     [Crossref] [Google Scholar]
  123. 123. 
    Taillie LS, Busey E, Stoltze FM, Dillman Carpentier FR. 2019.. Governmental policies to reduce unhealthy food marketing to children. . Nutr. Rev. 77:(11):787–816
     [Crossref] [Google Scholar]
  124. 124. 
    Thomas L. 2021.. 130 countries back global minimum corporate tax of 15%. Reuters. , July 1. https://www.reuters.com/business/countries-backs-global-minimum-corporate-tax-least-15-2021-07-01/
  125. 125. 
    Thorn M. 2018.. Addressing power and politics through action on the commercial determinants of health. . Health Promot. J. Aust. 29::225–27
     [Crossref] [Google Scholar]
  126. 126. 
    Turner T. 2021.. E-cigarette lawsuits. . Drugwatch. https://www.drugwatch.com/e-cigarettes/lawsuits/
    [Google Scholar]
  127. 127. 
    US Natl. Cancer Inst. (NCI), World Health Organ. 2016.. The economics of tobacco and tobacco control. NCI Tob. Control Monogr. 21. NIH Publ. 16-CA-8029A , US Dep. Health Hum. Serv., Bethesda, MD:. https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-21
    [Google Scholar]
  128. 128. 
    Voon T. 2015.. Evidentiary challenges for public health regulation in international trade and investment law. . J. Int. Econ. Law 18:(4):795–826
     [Google Scholar]
  129. 129. 
    Weber Shandwick, KRC Res. 2018.. Battle of the wallets: the changing landscape of consumer activism. Rep., Weber Shandwick, New York:. https://www.webershandwick.com/wp-content/uploads/2018/05/Battle_of_the_Wallets.pdf
    [Google Scholar]
  130. 130. 
    Weishaar H, Collin J, Smith K, Grüning T, Mandal S, Gilmore A. 2012.. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO Framework Convention on Tobacco Control. . PLOS Med. 9:(6):e1001249
     [Crossref] [Google Scholar]
  131. 131. 
    Whitehouse S. 2018.. ToxicDocs: using the US legal system to confront industries’ systematic counterattacks against public health. . J. Public Health Policy 39:(1):22–23
     [Crossref] [Google Scholar]
  132. 132. 
    WHO (World Health Organ.). 2017.. ‘Best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases. Updat. Append. 3 WHO Glob. NCD Action Plan 2013–2020 , WHO, Geneva:. https://www.who.int/ncds/management/WHO_Appendix_BestBuys.pdf
    [Google Scholar]
  133. 133. 
    WHO (World Health Organ.). 2019.. Health taxes: a primer. Policy Brief 19.7 , WHO, Geneva:
     [Google Scholar]
  134. 134. 
    WHO (World Health Organ.). 2021.. Litigation relevant to regulation of novel and emerging nicotine and tobacco products: case summaries. Rep., WHO, Geneva:. https://www.who.int/publications/i/item/9789240024182
    [Google Scholar]
  135. 135. 
    WHO (World Health Organ.). 2021.. Proposed programme budget 2022–2023. A74/5 Rev. 1 , WHO, Geneva:. https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_5Rev1-en.pdf
    [Google Scholar]
  136. 136. 
    Wiist WH. 2018.. Public health and corporate avoidance of US federal income tax. . World Med. Health Policy 10:(3):272–300
     [Crossref] [Google Scholar]
  137. 137. 
    Wilkinson AL, Scollo MM, Wakefield MA, Spittal MJ, Chaloupka FJ, Durkin SJ. 2019.. Smoking prevalence following tobacco tax increases in Australia between 2001 and 2017: an interrupted time-series analysis. . Lancet Public Health 4:(12):e618–27
     [Crossref] [Google Scholar]
  138. 138. 
    Wilson N, Morenga LT, Mackay S, Gerritsen S, Cleghorn C, et al. 2020.. Food taxes and subsidies to protect health: relevance to Aotearoa New Zealand. . N. Z. Med. J. 133:(1511):71–85
     [Google Scholar]
  139. 139. 
    Wood B, Baker P, Sacks G. 2021.. Conceptualising the commercial determinants of health using a power lens: a review and synthesis of existing frameworks. . Int. J. Health Policy Manag. https://doi.org/10.34172/ijhpm.2021.05
    [Crossref] [Google Scholar]
  140. 140. 
    Wood B, Ruskin G, Sacks G. 2020.. How Coca-Cola shaped the International Congress on Physical Activity and Public Health: an analysis of email exchanges between 2012 and 2014. . Int. J. Environ. Res. Public Health 17:(23):8996
     [Crossref] [Google Scholar]
  141. 141. 
    World Bank. 2019.. Global tobacco control and health taxes. . Understanding Poverty. https://www.worldbank.org/en/topic/tobacco
    [Google Scholar]
  142. 142. 
    Young B, Lewis S, Katikireddi SV, Bauld L, Stead M. 2018.. Effectiveness of mass media campaigns to reduce alcohol consumption and harm: a systematic review. . Alcohol Alcohol. 53:(3):302–16
     [Crossref] [Google Scholar]
  143. 143. 
    Zenone M, Silva D, Smith J, Lee K. 2021.. How does the British Soft Drink Association respond to media research reporting on the health consequences of sugary drinks?. Glob. Health 17::72
     [Crossref] [Google Scholar]
  144. 144. 
    Zoller HM. 2017.. Health activism targeting corporations: a critical health communication perspective. . Health Commun. 32:(2):219–29
     [Crossref] [Google Scholar]
  145. 145. 
    Zuboff S. 2019.. The Age of Surveillance Capitalism: The Fight for a Human Future at the New Frontier of Power. New York:: Public Affairs
     [Google Scholar]
/content/journals/10.1146/annurev-publhealth-052220-020447
Loading
Public Health Roles in Addressing Commercial Determinants of Health
Annual Review of Public Health 43, 375 (2022); https://doi.org/10.1146/annurev-publhealth-052220-020447
/content/journals/10.1146/annurev-publhealth-052220-020447
/content/journals/10.1146/annurev-publhealth-052220-020447
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error